Navigation Links
Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Date:1/25/2012

tions of available therapies contribute to the significant unmet need of affected patients.  CMX001 has the potential to fill this major unmet need and become the standard of care with its broad spectrum coverage of multiple viral infections, favorable safety profile, and convenient oral dosing."

"We are extremely enthusiastic about the positive data emerging from Study 201 and our other clinical studies for CMX001," said Kenneth I. Moch, Chimerix President and Chief Executive Officer.  "We look forward to initiating Phase 3 studies during 2012."  

Additional CMX001 Presentations
Additional presentations at BMT Tandem will include data supporting use of CMX001 as peri-engraftment therapy for hematopoietic cell transplant recipients and in pediatric patients with adenovirus.  Poster presentations begin on Wednesday, February 1. 

  • "CMX001 in the Peri-Engraftment Period Does Not Impair Neutrophil Recovery in Pediatric Allogeneic Hematopoietic Stem Cell Recipients," will be presented by Michael S. Grimley, MD, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center.
  • "CMX001 as Therapy for Severe Adenovirus Infections in Immunocompromised Pediatric Patients: Single Experience in 5 Patients," which will also be presented by Dr. Grimley.

 

About CMX001
CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosphate and has broad spectrum activity against dsDNA viruses. CMX001 is completing Phase 2 clinical development for the prophylaxis of cytomegalovirus (CMV) and is in Phase 2 development for the preemption and treatment of adenovirus infection in hematopoietic cell transplant recipients. Efficacy results from completed and ongoing studies, coupled with the lack of myelotoxicity and nephrotoxicity seen in curr
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences
2. Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital Transaction" Award
3. Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting
4. Chimerix to Present at Infocasts 9th Annual Biodefense Vaccines & Therapeutics Conference
5. Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
6. Chimerix to Present at Cowen and Company 31st Annual Health Care Conference
7. Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerixs Lead Antiviral CMX001
8. Chimerix to Present at the Citi 2011 Global Health Care Conference
9. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... MEADOWS, N.Y. , Dec. 15, 2014 ... the SPL (Structured Product Labeling) markup language standard, content ... the understanding and skills to work with the standard. ... a series of three webinars on the benefits and ... three one-hour webinars will be facilitated by Howard ...
(Date:12/15/2014)... , Dec. 15, 2014  The Government of Ghana ... AABB, Global Blood Fund (GBF) and Terumo BCT to respond to ... as well as provide long-term health system capacity to the citizens ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is ... preparations for the possible arrival of the Ebola epidemic ...
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ... "Drug Injection Devices to 2020" report to ... As new drugs become available ... health conditions, drug developers have increasingly pursued packaging ... and increase the efficiency and reliability with which ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... Feb. 28, 2011 Mylan Inc. (Nasdaq: MYL ... received final approval from the U.S. Food and Drug Administration ... Capsules USP, 100 mg, 300 mg and 400 mg, the ... treat a painful complication of shingles. Gabapentin ...
... SHENZHEN, China, Feb. 28, 2011 /PRNewswire-Asia/ -- Winner ... "Winner Medical"), a leading manufacturer of medical dressings, ... natural PurCotton® products in China, announced today that ... Rodman & Renshaw Annual China Investment ConferenceDate: , ...
Cached Medicine Technology:Winner Medical to Attend Investor Conferences in March 2Winner Medical to Attend Investor Conferences in March 3Winner Medical to Attend Investor Conferences in March 4
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s ... new study providing evidence on the impact of 100% ... , Sufficient enough evidence already exists showing a negative ... drinks, with the onset of tooth decay. One question ... as 100% fruit juice, meaning it is completely natural ...
(Date:12/15/2014)... 2014 SIMpalm, a leading mobile ... for iPhone for its client, which allows users to ... company, specialized in finding the right wine. At ... uses combined sensory, chemistry and wine information. All this ... “wine fingerprint.” Those wines that are close counterparts to ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... Expert pilots process visual information more efficiently than less ... during landings, a new study shows. Landing is ... master, and 36 percent of all airplane crashes and ... and landing. Researchers monitored the brain activity of ... they were at the controls of a flight simulator. ...
(Date:12/15/2014)... Kathy McAfee, America's Marketing Motivator, was announced ... the category of Best Blog 2014. McAfee received the ... career blog Networking Ahead which combines many ... their talent and influence through better networking, leadership and ... Networking Ahead for Business, has been motivating readers for ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... cancer cases in 2003.// Researchers have been mulling over the ... their attention. Nearly millions of women had abandoned hormone replacement ... out such a huge difference, is being debated over. ... the number of breast cancer cases, estimated at 14,000 women ...
... people with history of unprotected sex to have an ... transmission.// The announcement being the first case of such ... Thursday uncovered two clusters of HIV infections, HIV-1 subtype ... government scientists. They said that both the clusters found ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... researchers at the University of Pennsylvania Health System are ... the heart when its electrical pulses// essentially short-circuit, referred ... problem physicians run into with current therapies to cope ... pulmonary vein isolation procedures, is that up until now, ...
... the limit,’ but subsequently found to be below maximum permissible ... drugs, reveals research in Injury Prevention. ,The findings ... all drivers who are suspected of being over the limit ... 2000 blood and urine specimens taken from drivers who had ...
... a man’s heart is through his stomach, they say! Is that ... for thought, of course! Meanwhile, what could be the route to ... the lady of the house, says a new study. ... study of almost 200 British men and women, who were on ...
Cached Medicine News:Health News:New Tool Being Tested to Halt Recurrence of Atrial Fibrillation 2Health News:One in Three Drivers Under ‘The Limit’ for Alcohol Still Test Positive for Dru 2Health News:How a Woman Holds Fort in Her Little Kingdom – The Kitche 2
Custom Conjugation Services...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...
Medicine Products: